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Abstract
Protection by mild hypothermia has previously been associated with better mitochondrial
preservation and suppression of the intrinsic apoptotic pathway. It is also known that the brain may
undergo apoptotic death via extrinsic, or receptor mediated pathways, such as that triggered by Fas/
FasL. Male Sprague Dawley rats subjected to 2h middle cerebral artery occlusion with 2h
intraischemic mild hypothermia (33C) were assayed for Fas, FasL and caspase-8 expression.
Ischemia increased Fas, but decreased FasL by ~50–60% at 6 and 24h post insult. Mild hypothermia
significantly reduced expression of Fas and processed caspase-8 both by ~50%, but prevented
ischemia-induced FasL decreases. Fractionation revealed that soluble/shed FasL (sFasL) was
decreased by hypothermia, while membrane-bound FasL (mFasL) increased. To more directly assess
the significance of the Fas/FasL pathway in ischemic stroke, primary neuron cultures were exposed
to oxygen glucose deprivation. Since FasL is cleaved by matrix metalloproteinases (MMPs), and
mild hypothermia decreases MMP expression, treatment with a pan-MMP inhibitor also decreased
sFasL. Thus, mild hypothermia is associated with reduced Fas expression and caspase-8 activation.
Hypothermia prevented total FasL decreases, and most of it remained membrane bound. These
findings reveal new observations regarding the effect of mild hypothermia on the Fas/FasL and MMP
systems.
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Introduction
Hypothermia has long been known to be a potent neuroprotectant. Experimental studies
(Krieger and Yenari 2004) and now clinical trials (Bernard et al. 2002; Hypothermia after
Cardiac Arrest Study Group 2002) have shown that hypothermia protects the brain from
cerebral ischemic injury. Lowering body temperature is known to slow metabolism, prevent
high-energy phosphate depletion and prevent accumulation of excitotoxins such as glutamate.
However, even small decreases in body temperature are associated with a marked reduction in
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ischemic injury, and do not correspond to the expected Q10 for this protective effect (Yenari
et al. 2004). This would suggest that other processes may be involved in the observed
phenomenon. Work from our lab and others has shown that protection by mild hypothermia is
associated with the inhibition of apoptosis via the intrinsic or mitochondria dependent pathway
(Inamasu et al. 2000; Prakasa Babu et al. 2000; Zhang et al. 2001; Xu et al. 2002; Yenari et al.
2002; Zhao et al. 2005).
Recent work has also shown that extrinsic, or receptor mediated apoptosis pathways are
involved in stroke pathogenesis (Rosenbaum et al. 2000). Death receptors are cell surface
transmembrane proteins belonging to the tumor necrosis factor receptor superfamily, which
includes Fas (also referred to as CD95 or APO-1), one of the most studied death receptors. Fas
is a member of the tumor necrosis factor receptor superfamily, acting as a trigger for apoptosis
(Nagata and Golstein 1995). Its ligand, FasL, is a 40 kD type II transmembrane protein. Death
receptor-mediated apoptosis is a critical component of neuronal death in the developing and
adult mammalian nervous system, and Fas activation is a recurrent feature of acute and chronic
neuropathologies, including traumatic brain injury, multiple sclerosis, and Alzheimer’s disease
(D’Souza et al. 1996; Morishima et al. 2001; Qiu et al. 2002). Binding of Fas ligand (FasL) to
Fas initiates intracellular signaling cascades that ultimately terminate in caspase-dependent
cell death.
Fas also appears to play an important role in brain damage following focal cerebral ischemia.
Expression of Fas and its ligand have been documented in the brain following ischemia
(Padosch et al. 2003), and neutralizing FasL with antibody treatment is associated with
neuroprotection in experimental stroke models (Martin-Villalba et al. 2001; Blankenberg et al.
2006). Furthermore, Lpr mice containing dysfunctional Fas, have smaller infarcts than
wildtype mice (Martin-Villalba et al. 1999; Rosenbaum et al. 2000).
Matrix metalloproteinases (MMPs) can modulate Fas activation by causing proteolytic
shedding of FasL from the cell surface (Powell et al. 1999; Matsuno et al. 2001; Mitsiades et
al. 2001). Thus, shed or soluble Fas ligand (sFasL) is then liberated to bind to its receptor. Prior
work has shown that therapeutic hypothermia decreases MMP expression in stroke (Wagner
et al. 2003; Hamann et al. 2004; Lee et al. 2005).
In this study, we explored the effects of mild hypothermia on the extrinsic Fas-mediated
apoptosis pathway. We found that mild hypothermia suppressed expression of Fas and
activation of caspase-8, but increased FasL expression. However, FasL was largely membrane
bound under hypothermic conditions, probably due to decreased cleavage by MMPs.
Materials and Methods
Animal model
All experiments were performed following an institutionally approved protocol in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Brain ischemia was induced using an intraluminal suture to occlude the middle cerebral artery.
Briefly, a total of 46 male Sprague-Dawley rats (22 maintained at normothermia, 22 exposed
to hypothermia and 2 used as shams) weighing between 250–300g were anesthetized with 3–
4% halothane in 30% oxygen and 70% nitrous oxide using a face mask for induction, and
maintained at 1–1.5%. The right femoral artery was cannulated to record blood pressure and
to obtain arterial blood samples. After a midline skin incision was made, the right external
carotid artery was exposed, and its branches were electrocoagulated. A 3-0 nylon monofilament
coated with silicon was introduced into the right internal carotid artery through the external
carotid artery to occlude the origin of the middle cerebral artery. After 2 h of arterial occlusion,
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blood flow was restored by withdrawal of the nylon suture. Sham control animals were
subjected to similar operations to expose the carotid arteries without occlusion of the middle
cerebral artery. Physiological parameters were monitored and kept in the normal range. During
surgery, each rat’s rectal temperature was kept between 37 and 38°C, which corresponds to a
brain temperature between 38 and 39°C (Yenari et al. 2000). Mild hypothermia, defined as a
rectal temperature of 32°C, which corresponds to a brain temperature of 33°C, was induced
and maintained in a manner previously described (Yenari et al. 2000). This paradigm has
consistently shown consistent neuroprotection in our hands (Yenari et al. 2000; Maier et al.
2001). The animals were cooled by placing the animal on a cooling blanket and spraying
ethanol onto the body at the time of ischemia onset (intraischemic hypothermia), and
hypothermia was maintained for 2 h. Rewarming took place by placing the animal under a
lamp and on a heating blanket.
Preparation of tissue extracts
At 2, 6, and 24 h after the onset of ischemia, rats were deeply anesthetized with halothane and
then transcardially perfused with ice-cold phosphate buffered solution (PBS), pH 7.4. The
brains were removed quickly and divided into ipsilateral and contralateral hemispheres. Based
on methods outlined in our prior studies, 1–3 mg samples of ischemic tissue from the ipsilateral
striata (SI), adjacent cortex in the middle of the infarction (CI) and the periphery of the infarct
at its upper medial border (PI), plus corresponding tissue from the contralateral hemisphere
was dissected, frozen immediately on dry ice, and stored at −80C (Yenari et al. 2002). Brain
samples were homogenized in lysis buffer with protease inhibitors on ice. Brain samples from
non-ischemic animals were also prepared. After centrifugation, supernatant was collected, and
total protein concentrations were determined using the Bradford assay (Bio-Rad, Hercules,
CA).
To detect soluble/shed and membrane-bound Fas ligand, brain samples were prepared using
previously published protocols (Bright et al. 2004). Tissue was homogenized in lysis buffer
containing 0.5 M EDTA, 1M Tris pH7.5, 0.1M EGTA, 855 mg sucrose plus protease inhibitors.
The homogenate was then centrifuged at 100,000 G for 30 min at 4C. The supernatants (soluble
fraction) were collected and the pellets were resuspended in lysis buffer plus 0.1% triton and
spun again after sitting on ice for 20 min. The second supernatant was collected and used as
the particulate (membrane containing) fraction. 10 μg protein were loaded per lane, and
subjected to sodium dodecyl sulfate polyacrylamidegel electrophoresis and Western blot
analysis.
Western blot analysis
Fas, FasL and caspase-8 protein expression was estimated in hypothermic and normothermic
brains after ischemic injury using Western blots. Total tissue extracts were prepared at various
times after ischemic injury using methods familiar to us (Yenari et al. 2002; Lee et al. 2005).
In all cases, equal amounts of protein (30 μg/lane) were subjected to electrophoresis in 12.5%
polyacrylamide gels, and transferred to nitrocellulose membranes (Millipore, Bedford,
Massachusetts, U.S.A.). After 2 h of blocking, membranes were incubated in primary
antibodies against Fas (1:500, rabbit polyclonal antibody, C-20, Santa Cruz Biotechnology,
Inc., CA, USA), FasL (1:500, rabbit polyclonal antibody, N-29, Santa Cruz) or caspase-8
(1:1000, rabbit polyclonal antibody, AAP-103, StressGen, Victoria, BC Canada) followed by
appropriate secondary antibodies. Finally, antigen was detected by using the standard chemical
luminescence method (ECL; Amersham Pharmacia Biotech). The membranes were stripped,
then reprobed with monoclonal anti-β-actin antibody (1:1000, A-5441, Sigma) or G protein
alpha inhibiting 3 (Gαi3, 1:1000, SC-262, Santa Cruz)and developed as above. Densitometric
measurements were made from the protein bands using Gelscope (Imageline, Gardena, CA).
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Histology and Immunostaining
2, 6 and 24 h after the onset of ischemia, brains were perfused in normal saline followed by
3% paraformaldehyde, then sunk in sucrose. Tissue sections were cryosectioned in the coronal
plane into 25 μm thick slices, rinsed, blocked, and incubated overnight at 4C with the primary
antibodies (1:200 dilution, Fas, FasL and caspase-8 as above) followed by the secondary
antibody (Vector Labs, Burlingame, CA). Antibodies were detected using the Elite Vectastain
ABC kit (Vector Labs) and colorized with diaminobenzidine (DAB, DAKO Corporation,
Carpenteria, CA). Sections were counter stained with hematoxylin and eosin (H & E), cleared
and mounted in permount. H & E stained sections from brains of animals survived 24 h were
also analyzed for infarct size using methods previously published, including correction for the
presence of edema (Maier et al. 1998; Yenari et al. 2000).
To determine the source of Fas and FasL production, double labeling for cell type markers was
performed. Tissue sections were treated with proteinase K (1:2 dilution, Dako Corp.) for 15
minutes then washed in PBS. The sections were blocked in PBS containing 5% normal serum,
1% bovine serum albumin, and 0.3% Triton X-100 for 1 h at room temperature, after which
they were incubated in primary antibodies diluted in blocking solution at 4°C overnight. Tissue
sections were washed with PBS and incubated for 2 h at room temperature (light shielded) in
secondary antibodies diluted in blocking solution. Slides were covered and the tissue was
examined with the aid of a fluorescence microscope (Carl Zeiss, Switzerland). For double
labeling, primary murine antibodies used to identify neurons (NeuN; 1:200, cat. # MAB377,
dilution; Chemicon Corp, Billerica, MA), astrocytes (GFAP, 1:100, cat. # 556330,
Pharmingen, San Diego, CA), or macrophages/microglia (OX42, 1:1000 dilution; AbCAM,
Cambridge, MA) were combined with the above described primary antibodies against Fas or
FasL. The secondary antibodies were FITC (fluorescein isothiocyanate)-conjugated goat anti
rabbit IgG (1:400 dilution, Jackson ImmunoResearch, West Grove, PA), and Cy3-conjugated
anti–mouse IgG (1:100 dilution; Jackson ImmunoResearch).
Primary neuronal cultures
To further determine the effects of hypothermia on FasL and its regulation, primary neuronal
cultures were established from cerebral cortices of C57BL/6 embryos at gestation day 15
(Harlan, Indianapolis, IN), using enzymatic dissociation with trypsin as previously described
(Xu et al. 2002). Timed pregnant females were sacrificed by halothane overdose and the
embryos were removed by cesarean section. 4.8 × 105 cells were plated on poly-L-lysine-coated
coverslips in 24 well plates. Cultures were maintained in Neurobasal media (Invitrogen Corp.,
Carlsbad, CA) supplemented with 2% B-27, 0.5 mM glutamine (Sigma, St. Louis, MO), 25
μM glutamate (Sigma), 100 units/ml penicillin, and 100μg/ml streptomycin. At 4 d in vitro
(DIV) half of the media was removed and replaced with fresh medium without glutamate.
Cultures were maintained in a humidified incubator at 37C with 5% CO2. At 7 DIV cultures
were used for experimentation. The cortical cultures were primarily comprised of >95%
neurons as identified by NeuN immunostaining.
Oxygen and glucose deprivation (OGD)
Cultures were subjected to OGD in balanced salt solution containing no glucose (BSS0) in an
anoxic chamber (Coy Laboratories, MI) with O2 tension <0.02%. Cultures were subjected to
OGD for 3 h. Upon removal from the anoxia chamber, 5.5 mM glucose was added and the
cultures returned to the normoxic incubator (i.e., reperfusion) for 24 h. Hypothermic cultures
were exposed to both OGD and reperfusion at 33C, while normothermic cultures were exposed
at 37C. Cell death was quantified by assay of released lactate dehydrogenase (LDH) expressed
as a percent of the total LDH released after freeze-thaw (=100%). Control cultures were
incubated at normoxia in balanced salt solution containing 5.5 mM glucose (BSS5.5). To some
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cultures, GM6001, an MMP inhibitor (50 nM, Sigma) was added to the media at the onset of
injury.
Statistical analysis
All data are presented as mean ± SD. Standard statistical tests were used to determine
differences between groups using SigmaStat (Jandel Corp., San Rafael, CA). The Student’s t-
test or ANOVA were used in the case of continuous data (e.g., infarct size), and Mann-Whitney
for non-continuous data (semi-quantitative scores). A level of P < 0.05 was considered
statistically significant.
Results
Mild hypothermia decreased infarct size by ~60% (Fig. 1). This was not associated with any
significant differences in physiological parameters except temperature. Parameters monitored
included (normothermia, then hypothermia data given): rectal temperature (37±0.1C, 32.5
±0.1C), mean arterial blood pressure (92±2, 94±4 mmHg), heart rate (335± 5, 315±5),
respiratory rate (54±6, 45±7), pH (7.32±0.03, 7.32±0.01), pO2 (100±5, 114±4), and pCO2 (47
±2, 49±2).
Mild hypothermia reduces caspase-8 and Fas expression, but increases FasL
Immunostaining for Fas and FasL revealed that both proteins were expressed largely within
neurons and astrocytes, and were rarely seen in microglia (Figs. 2A & B). Ischemia led to
increases in neuronal and astrocytic Fas, and decreases in FasL (Figs. 2C & D). Fas and FasL
was primarily seen within the ischemic cortex, with some staining observed in the ischemic
striatum. Hypothermia decreased Fas and increased FasL staining compared to normothermia
(Fig. 3). However, the types cell which expressed these respective proteins were similar. Since
the antibody used to identify caspase-8 does not differentiate between pro- and processed
caspase-8, immunostains did not show significant differences in staining patterns following
ischemia, or following treatment with mild hypothermia (not shown).
Protein levels of caspase-8, Fas, and FasL taken at various times from the ipsilateral ischemic
cortex (CI) were quantified using Western blots. The total amount of caspase-8 protein was no
different between hypothermic brains and normothermic brains after ischemic injury, but the
amount of processed caspase-8 was lower in hypothermic brains (Fig. 4). Ischemia at normal
temperature increased Fas, and hypothermia decreased Fas 2 and 24 h post ischemia, with
trends observed at 6 h (Fig 5). In contrast, ischemia at normal temperature led to decreased
FasL, while hypothermia prevented this FasL decrease, especially 6 and 24h post ischemia
(Fig 6).
FasL remains largely membrane bound in hypothermic brains after ischemic injury
compared to normothermia
FasL is normally bound to membrane surfaces, but is shed through cleavage by proteases such
as the MMPs, thus producing soluble/shed FasL (sFasL). To explore the effect of hypothermia
on sFasL versus membrane bound FasL (mFasL), we performed Western blots of particulate
(membrane) and soluble fractions from ischemic brain samples. Samples were taken from the
ipsilateral ischemic striatum (SI), ischemic cortex (CI) and infarct borderzone (PI). Not only
did mild hypothermia lead to higher total levels of FasL, but most of the FasL was membrane
bound, and mFasL levels were greater in hypothermic brains than in normothermic brains (Fig.
7). Soluble/shed FasL levels, in contrast, were lower in hypothermic brains.
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FasL remains membrane bound due to hypothermic suppression of MMPs
Because we found that FasL was expressed in neurons, we studied primary neuronal cultures
to explore the mechanism of reduced FasL shedding by hypothermia. Since we previously
showed that mild hypothermia was associated with suppression of MMP expression and
function, we determined whether the decreased sFasL observed in hypothermic brains was due
to decreased shedding of membrane bounded FasL by MMPs. Primary cultured neurons were
exposed to OGD under hypothermic conditions. Some cultures were treated with GM6001, a
pan-MMP inhibitor. Hypothermia led to increased mFasL levels, while decreasing sFasL
compared to normothermia, consistent with our in vivo observations (Figure 8). This was the
case even in cultures not exposed to OGD. Normothermic neuron cultures treated with GM6001
and subjected to OGD had less sFasL, and slightly more mFasL compared to untreated
normothermic cultures exposed to OGD. The combination of hypothermia and GM6001 led
to further increases in mFasL and decreases in sFasL. This would be consistent with the notion
that hypothermia prevents cleavage of FasL, in part, by suppression of MMPs.
Discussion
Mild hypothermia has been shown to be an effective treatment against cerebral ischemic injury
by numerous groups. Lowered body temperatures are thought to preserve metabolic stores and
are associated with decreased accumulation of excitatory amino acids, but this does not fully
explain the remarkably robust effects of cooling (Liu and Yenari 2007). A few studies have
already shown that mild hypothermia suppresses ischemia-induced apoptosis as evidenced by
fewer apoptotic/apoptotic-like cells and biochemical events largely associated with the
intrinsic, or mitochondrial pathway (Maier et al. 1998; Inamasu et al. 2000; Prakasa Babu et
al. 2000; Zhang et al. 2001; Zhao et al. 2005). Hypothermia can also directly reduce apoptotic
death, as a study of serum deprivation in cultured neurons led to reduced cell death by
hypothermia through the mitochondrial pathway (Xu et al. 2002). Hypothermia also renders
cells more resistant to apoptotic stimuli including Fas ligation (Fu et al. 2004; Sakurai et al.
2005). In one study of hepatocytes, decreasing culture temperature from 37C to 32C suppressed
Fas-mediated apoptosis and led to less cytochrome c release and activation of caspases-7 and
9. We show here that protection by hypothermia is associated with decreased Fas and processed
caspase-8, and the prevention of FasL decreases.
Immunostaining showed that both Fas and FasL colocalized primarily to neurons and astrocytes
rather than microglia. This is in line with our previous observations that caspase-8 is also
observed primarily in neurons (Blankenberg et al. 2006). Ischemia led to increased Fas, and
decreased FasL expression within the same types of cells. A prior study documented increases
in FasL staining following focal cerebral ischemia, which is in contrast to the findings here
(Martin-Villalba et al. 1999). The reason for this difference is not clear, but we should point
out that the duration of occlusion in our study was somewhat longer than that of the prior study
(2 h compared to 90 min), and might be consistent with some reports that some apoptosis
related proteins are not present in some models of brain ischemia (Gill et al. 2002).
Furthermore, we sampled brain tissue from the dorsal aspect of the ischemic lesion, whereas
the prior studied sampled tissue from the ventral aspect in the piriform cortex.
We also found that hypothermia prevented decreases in overall FasL expression, and FasL was
mostly membrane bound. Soluble/shed FasL was still lower in the hypothermia group. This
observation is probably due to hypothermia-induced suppression of MMPs, which has
previously been demonstrated by our group and others (Wagner et al. 2003; Hamann et al.
2004; Lee et al. 2005). Thus, we show that hypothermia prevents MMP-induced FasL shedding
and reduces Fas expression and caspase-8 activation. Since neurons and astrocytes expressed
both Fas and FasL, it is possible that FasL binds neuronal and glial Fas in an autocrine and/or
paracrine fashion in the models studied here. Although rare microglia also expressed FasL, it
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seems less likely that microglia-generated sFasL contributed to Fas stimulation. We also
observed overall decreases in Fas by mild hypothermia which would provide fewer receptors
for sFasL to bind to. The reduction in Fas is probably not due to decreased sFasL, but decreased
activation of nuclear factor kappa B (NFkB) by hypothermia (Han et al. 2003; Yenari and Han
2006) since NFkB is known to regulate FasL expression (Chan et al. 1999).
At present, few data are available regarding the role of Fas and FasL after cerebral ischemia.
In models of cardiac arrest, Fas and FasL were expressed in the cortex and hippocampus after
6 h and 12 h after ischemia, with peak expression at 24–48 h (Padosch et al. 2003). Although
Fas/FasL were originally characterized in the immune system, we found that non-immune cells
express Fas and FasL. This is also consistent with prior reports (Rosenbaum et al. 2000; Qiu
et al. 2002). Prior studies have suggested a detrimental effect of the Fas signaling pathway in
experimental stroke, as treatment with Fas antibody or studying mice deficient in Fas led to
less ischemic injury (Martin-Villalba et al. 1999; Martin-Villalba et al. 2001; Blankenberg et
al. 2006), while overexpression of FasL led to increased apoptosis in a model of traumatic brain
injury (Qiu et al. 2002).
Consistent with our findings presented here, a prior study in a similar stroke model showed
that mild hypothermia was associated with decreased Fas and caspase-3 immunostaining
(Phanithi et al. 2000). However, this latter study did not assess the influence of hypothermia
on FasL or caspase-8. The present study further demonstrates that while hypothermia prevents
the loss of FasL, most FasL remained membrane-bound. These observations could be linked
to hypothermia’s ability to inhibit MMPs (Wagner et al. 2003; Hamann et al. 2004; Lee et al.
2005), proteases involved not only in disrupting the extracellular matrix, but also involved in
cleaving and thus solubilizing FasL (Mitsiades et al. 2001). We show that inhibiting MMPs in
our in vitro model led to decreased sFasL and increased mFasL, which was similar to that seen
in cultures exposed to hypothermia. Interestingly, combining MMP inhibition with
hypothermia led to even further decreases in sFasL. The reasons for this latter observation are
not clear, but indicate synergy between the two interventions and may have translational
relevance. Our findings also demonstrate the broad impact hypothermia has on various cell
signaling systems.
The finding that mild hypothermia reduces sFasL is curious, as this might be consistent with
a pro-apoptotic, pro-death role of sFasL. There are conflicting data as to whether FasL shedding
leads to an active protein or not. FasL shedding, mediated by MMP-7 or -3 (Cunningham et
al. 2005), has been thought to actually inactivate FasL thus preventing effective binding of Fas.
Work in the cancer and immunology literature indicates that cleavage of FasL leads to increased
resistance of tumor cells to chemotherapeutic agents (Mitsiades et al. 2001) and apoptosis
(Knox et al. 2003). Increased levels of the MMP-3 inhibitor TIMP (tissue inhibitor of
metalloproteinase)-3 were detected in brain regions with the most severe ischemia (Wallace
et al. 2002). Inhibition of TIMP-3 has also been shown to prevent doxorubicin-induced
apoptosis of neurons, presumably by allowing MMP-3 mediated FasL cleavage (Wetzel et al.
2003), and TIMP-3 deficiency led to decreased apoptosis due to brain ischemia in mice (Wetzel
et al. 2008). Yet, in the work shown here, less apoptosis/apoptosis-like cell death was seen
under hypothermic conditions, and this was associated with decreased FasL shedding. Active
sFasL has been detected in some systems. Powell and colleagues (Powell et al. 1999) showed
that MMP-7-generated sFasL caused apoptosis in prostate epithelial cells. The differences in
the interpretation and significance of soluble FasL are not clear, but could due to inherent
differences in the models and organ systems studied. It is also possible that different MMPs
may cleave FasL at different sites so as to produce biologically different proteins.
In summary, we show that mild hypothermia alters expression and processing of proteins of
the extrinsic Fas/FasL apoptotic pathway, and builds on prior observations that hypothermia
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decreases MMP activation. While largely thought to affect down regulation of cellular
metabolism, we demonstrate the impact of hypothermia on other signaling pathways as well.
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MMP  
matrix metalloproteinase
sFasL  
soluable Fas ligand
mFasL  
membrane bound Fas ligand
PBS  
phosphate buffered solution
FITC  
fluorescein isothiocyanate
DIV  
days in vitro
OGD  
oxygen glucose deprivation
Bss0  
balanced salt solution
BSS5.5  
balanced salt solution containing 5.5 mM glucose
LDH  
lactate dehydrogenase
NKkB  
nuclear factor kappa B
TIMP  
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relative optical density
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non ischemic brain
SI  
ischemic striatum
CI  
ischemic cortex
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PI  
ischemic peri-infarct region
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Figure 1.
Mild hypothermia reduces infarct size 24h after ischemia onset. Infarct size, measured from H
& E stained sections, was reduced among animals exposed to mild hypothermia (expressed as
the % injury of the ipsilateral hemisphere). Data are shown with and without correction for
edema. (*P<0.05, **P<0.01, white bars=normothermia, black bars=mild hypothermia, n=6/
group).
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Figure 2.
Fas and FasL expression in the brain. Double immunolabeling of the cortex of uninjured rats
shows that both Fas (A) and FasL (B) are present within neurons and astrocytes, but not
microglia. Following 24 h ischemia, Fas (C) expression increases in both neurons and
astrocytes, with rare expression in microglia, whereas FasL (D) decreases in neurons and
astrocytes. Brain regions within the ipsilateral ischemic cortex are shown. (Neun=neuronal
marker, GFAP=glial fibrillary acid protein to identify astrocytes, OX42=binds to CD11b to
identify microglial/monocytes; scale bar = 20 μm)
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Figure 3.
Immunohistochemical stains show that within brain exposed to 2 h ischemia and 22 h
reperfusion, mild hypothermia reduces Fas expression (A), but increases expression of FasL
(B). Representative images are taken from within the ischemic striatum (A) and cortex (B).
(scale bar = 50 μm)
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Figure 4.
Mild hypothermia reduces expression of processed caspase-8: A representative Western blot
(A) of the ipsilateral ischemic cortex (CI, defined in the text) shows decreased processed
caspase-8 (lower band) in brains of animals treated with mild hypothermia (33C) compared to
normothermia (38C). Pro-caspase-8 expression (upper band) was not changed by mild
hypothermia. Relative optical densities (ROD) of processed caspase-8 were lower in ischemic
brains of animals exposed to mild hypothermia (white bars) compared to normothermia (black
bars). Data are shown as the ROD of processed (activated) caspase-8 normalized to the actin
ROD, used as a loading control (*P<0.05, n=3–4/ bar) (B).
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Figure 5.
Mild hypothermia reduces Fas expression. A Western blot (A) of non ischemic brain (NI) and
brain from the ipsilateral ischemic cortex (CI, defined in the text) shows increased Fas
expression following ischemia at normothermia (38C). In animals exposed to mild
hypothermia (33C), Fas expression decreased compared to normothermia (38C). Relative
optical densities of Fas were lower in ischemic brains of animals exposed to mild hypothermia.
Data are shown as the relative optical density (ROD) of Fas normalized to the β-actin ROD,
used as a loading control (*P<0.05, white bars=hypothermia, black bars=normothermia, n=3–
4/ bar) (B).
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Figure 6.
Mild hypothermia prevents decreased expression of FasL. A representative Western blot (A)
of non ischemic brain (NI) and brain from the ipsilateral ischemic cortex (CI, defined in the
text) at normothermia (38C) shows decreased FasL (lower band) in ischemic brains. FasL in
brains of animals treated with mild hypothermia (33C) does not decrease following ischemia.
Relative optical densities (ROD) of FasL were lower in ischemic brains of animals exposed to
mild hypothermia compared to normothermic ischemic brains. Data are shown as the ROD of
FasL normalized to the actin ROD, used as a loading control (*P<0.05, white
bars=hypothermia, black bars=normothermia, n=3–4/ bar) (B).
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Figure 7.
FasL remains mostly membrane bound under conditions of mild hypothermia. Western blots
of particulate (mFasL) and soluble (sFasL) ischemic brain tissue fractions (24 h after ischemia
onset) revealed less soluble and more membrane bound FasL among hypothermic brains
compared to normothermic brains (A). A Western blot of housekeeping protein Gαi3, found
only in cell membranes, shows successful separation of the two fractions (B). Mild hypothermia
(33C) reduced the amount of sFasL, but increased the amount of m FasL (*P<0.05 vs.
corresponding normothermic samples, **P<0.01 vs. corresponding normothermic samples,
n-3-4 samples/bar). SI=ischemic striatum, CI=ischemic cortex, PI=peri-infarct cortex (C)
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Figure 8.
Mild hypothermia prevents FasL cleavage by inhibiting MMPs. Cultured neurons were
exposed to oxygen glucose deprivation (OGD) under normothermic (37C) or mild hypothermic
(33C) conditions. Some cultures were treated with the pan-MMP inhibitor GM6001. Control
cultures were kept in balanced salt solution containing 5.5 mM glucose (5.5). A. Western blots
of control or OGD exposed cultures of the soluble fraction (sFasL) showed less sFasL under
conditions of mild hypothermia, but more membrane bound FasL (mFasL). Cultures treated
with GM6001 at 37C were no different from cultures treated at 33C. Cultures exposed to OGD
at 33C and treated with inhibitor had further increases in mFasL and decreases in sFasL. B.
Western blot data are shown as the ratio of relative optical densities of the soluble to membrane
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fractions. Results are shown from 3 experiments performed in triplicate from cells prepared
from 3 separate dissections. (33, 37=culture temperature; 5.5=control wash; +=GM6001; +=no
GM6001; *P<0.05, **P<0.001)
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Figure 9.
Proposed FasL/ MMP interactions in ischemia/ischemia-like insults and modulation by mild
hypothermia. Activated matrix metalloproteinases (MMPs) are capable of cleaving membrane
bound FasL, and generating soluble FasL. Soluble FasL can then bind its receptor (Fas) and
trigger apoptosis through the extrinsic, or receptor mediated pathway by activating caspase-8.
Mild hypothermia appears to inhibit this pathway by inhibiting MMPs.
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